- Case Report
- Open Access
- Published:
Systemic anaplastic large cell lymphoma presenting as a huge mediastinal mass in a case of hyper IgE syndrome: a case report
Egyptian Journal of Radiology and Nuclear Medicine volume 50, Article number: 36 (2019)
Abstract
Background
Hyper IgE syndrome is a rare heterogeneous immunodeficiency syndrome which is characterized by recurrent episodes of cutaneous and respiratory tract infections and development of cold abscesses. This syndrome is also associated with malignancies, most notability hematologic malignancies.
Case presentation
In this case report, we discuss a 27-year-old male with proven hyper IgE syndrome and effected by tuberculosis, who developed an anaplastic large cell lymphoma, a very rare and aggressive subtype of lymphoma. We will discuss imaging findings in this rare case. The case presented here had a large mediastinal mass, which had encircled the aorta, and was accompanied by subcarinal lymphadenopathy and inguinal lymphadenopathy.
Conclusions
Systemic anaplastic large cell lymphoma is a rare subtype of lymphoma which is rarely associated with hyper IgE syndrome. In this case, both lymphoma and tuberculosis infection were witnessed in the same patient, showing a classic example of immune dysregulation.
Background
Hyper immunoglobulinemia E (IgE) syndrome is a heterogeneous group of disorders characterized by immune dysregulation. Davis et al. [1] reported the first case of hyper IgE syndrome in 1966, in two girls with chronic dermatitis and cold abscesses, and named the condition “Job’s syndrome.” Later, it was discovered that indeed Job’s syndrome was a subtype of hyper IgE syndrome, with an autosomal dominant form of transmission. To some extent, all forms of hyper IgE syndrome present with findings such as chronic dermatitis, recurrent cutaneous infections, chronic sinusitis, pneumatoceles, atopy, and increased rate of certain malignancies, most notably lymphomas. Immunologically, this condition is accompanied by reduced IL-22, IL-21, IL-11, IL-10, and IL-17 signaling; reduced chemotaxis of neutrophils; and abnormal differentiation of B lymphocytes [2]. Because of the latter, patients suffering from hyper IgE syndrome are prone to aggressive lymphomas. In this case report, we present a patient with documented hyper IgE syndrome who suffered from recurrent infections in the respiratory tract and the skin, and had been diagnosed and was being treated for tuberculosis. This patient developed an anaplastic lymphoma during follow-up, which presented as a huge mediastinal mass.
Case presentation
A 27-year-old male presented with a chief complaint of cough exacerbation within the previous month.
He was a known case of hyper IgE Syndrome for 17 years with a history of recurrent pneumonia, chronic sinusitis, skin rashes, nail infections, coarse texture of the skin, and delayed dental shedding.
He had a family history of a similar condition in his elder brother and sister, causing an early death in both siblings because of sepsis. The medical records of both siblings were unfortunately not available, but genetic analysis of the patient had revealed a mutation in the STAT3 gene.
From childhood, as the disease had begun, the patient experienced recurrent episodes of respiratory tract infections and rashes on the skin. The lesions were superinfected, and the patient was on medication with anti-staphylococcus agents, which had resulted in moderation of the skin lesions.
He had lost light perception in his right eye when he was 12 years old due to cutaneous lesions and their superimposed infections.
A year ago, he was admitted to a pulmonary subspecialty ward because of pneumonia (with fever and chills, productive coughs, and yellow-brown sputum), was diagnosed with tuberculosis during clinical examination, and received the classic TB treatment, comprising of rifampin, isoniazid, ethambutol, and pyrazinamide (10–15 mg/kg of each medication).
Two months after starting the anti-TB medications, due to high liver functional enzymes (SGOT = 89 to > 77 to > 135, SGPT = 99 to > 101 to > 77) and a high ALK.P (4847 to > 4175 to > 991) in a number of lab tests, all TB medications were halted and the patient underwent further evaluation.
He underwent abdominal and pelvic CT scan which showed an enlarged liver (liver span in longest dimension equaled 20 cm) with 2 hypodense masses with a maximum diameter of 17 mm. Numerous large hypodense masses in both inguinal regions suggestive of lymphadenopathy and a mass-like lesion with a diameter of 41 × 77 mm in LLQ were found. The patient chose not to continue further evaluations and left the hospital on personal demand.
Twenty days prior to the last admission, the patient was admitted to the hospital because of cough exacerbation, fever, and chills. Reduced lung sounds and fine crackles were auscultated in both lung bases, and the liver was 5 cm below the rib cage.
He received antibiotics and supportive treatment for pulmonary infection and underwent chest radiography, which showed a huge mass in the left thoracic cavity, just above the heart. Because of this, the patient had a CT scan with intravenous contrast, which showed an infiltrative large mass of 60 × 78 mm in the left para-mediastinum with aortic encasement and subcarinal lymphadenopathy. Numerous nodules with a maximum diameter of about 17 mm were also seen in both lungs. A mosaic pattern with ground glass opacification and an increase in intralobular septum thickness were observed. A consultation with a clinical oncologist suggested biopsy of the lesions. Imaging findings of the patient are presented in Figs. 1, 2, 3, 4, 5, and 6.
Two chest X-rays of the patient taken 1 year apart. a The chest X-ray taken when the patient was diagnosed with tuberculosis. b The chest X-ray taken when the patient had exacerbated symptoms after 1 year. A giant mass is seen in the mediastinum, which was not present before. The asterisk marks the described lesion
CT scan of the lungs and mediastinum with and without contrast. a An enlarged mass exists in the mediastinum. b Venous phase of CT with contrast shows that the aortic arch is encased by a mass which is not enhanced
Subcarinal lymphadenopathy detected by CT with venous contrast. The lymphadenopathy is shown by the asterisk
Triple-contrast CT scan of the abdomen. Low attenuated lesions are seen in the liver (arrows)
Bilateral inguinal lymphadenopathy showed by the arrows
Coronal and axial cuts of the sinuses. Ostiomeatal complex pattern is seen, as both the ethmoidal, maxillary, and frontal sinuses are involved
Bronchial biopsy and washing were not diagnostic; therefore, open lung biopsy was performed after consultation with the thoracic surgery specialists and immunohistochemical analysis of the specimen showed strong immune reactivity of all large neoplastic cells for CD30 and their negative reaction for CD3, CD15, CD20, CD45, CK, S100, and vimentin. Numerous reactive CD20+ CD45+ B cells and many reactive CD3+ CD45+ T cells were also seen, which overall were in favor of anaplastic large cell lymphoma. Further examination revealed a positive Ki-1 marker. Further consultation with the oncology department resulted in the patient being treated with the CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone). The patient was under treatment with this regimen for 2 months and was being considered to undergo treatment with brentuximab vedotin, until an episode of neutropenic fever caused the patient to be hospitalized in the ICU ward. The patient deteriorated swiftly and died within the first week of ICU hospitalization.
Discussion
In this article, we report a case of hyper IgE syndrome with typical dermatologic manifestations which was complicated by both a tuberculosis infection and an anaplastic large cell lymphoma. The first paramedical findings leading us to the diagnosis of lymphoma were a large mass in both chest X-rays and lung CT scans, which had encircled the aorta. Immunohistochemically, staining was done on a biopsy specimen of the lung, which yielded the definite diagnosis. Hyper IgE syndrome is associated with a dysfunctional immune response, which can present both as susceptibility to infectious agents and autoimmune diseases. Importantly, clinicians have observed that hyper IgE syndrome is associated with Hodgkin’s and non-Hodgkin’s lymphoma, especially the autosomal dominant subtype, which is associated with STAT3 deficiency [3]. Interestingly, both pro-inflammatory and anti-inflammatory responses are mediated through STAT3 signaling. Tangible evidence of this role is seen in hyper IgE syndrome, where both anti- and pro-inflammatory responses are dysfunctional [4].
Another form of hyper IgE syndrome is the autosomal recessive subtype, which is caused by a deficiency in dedicator of cytokinesis 8 (DOCK8), a molecule involved in the regulation of actin, and possibly a tumor suppressor. Clinically, this subtype is not associated with connective tissue diseases, while it is mostly associated with neurologic symptoms, mucocutaneous viral infections and asthma, and food allergies, unlike the autosomal dominant type [5, 6].
Although these two subtypes have different clinical manifestations and pathophysiological processes, they are both associated with malignancies, including lymphomas. A number of case reports have shed light on patients with hyper IgE syndrome who have been diagnosed with lymphomas. These reports have found that most patients have suffered of either diffuse large B cell lymphomas, T cell lymphomas, Burkitt lymphomas, Mantle cell lymphoma, Hodgkin’s lymphoma, or rare cases of extranodal NK/T lymphomas [7]. In this case report, we present a patient with a history of hyper IgE syndrome who was diagnosed with anaplastic large cell lymphoma, a very rare finding, of which only one has been reported so far [8], and in a rather young age (27 years old). This subtype of lymphoma is characterized by the presence of CD30 and Ki-1 tumor markers and is associated with cutaneous involvement, involvement of the skeletal system, spleen, liver, and soft tissues. The pathophysiology of this rare subtype of lymphoma is associated with the activation of anaplastic lymphoma kinase, a receptor tyrosine kinase in the insulin receptor superfamily [9]. Of interest, in vivo studies have suggested that there may be a link between anaplastic lymphoma kinase activation and STAT3, and the combined function of these two molecules may protect hematopoietic cells from apoptosis [10].
This patient also used to suffer from tuberculosis, again a rather rare finding, as most patients with hyper IgE syndrome are complicated by gram-positive bacteria. Furthermore, our case was novel in regard to imaging findings, as no other case had presented with a large mass in the mediastinum.
A general overview of previous case reports published in this regard reveals that CT scan has been the most utilized imaging method of lymphomas, and findings have included involvement of the parotid glands, spleen, and abdominal, mediastinal, and inguinal lymph nodes. Various studies have reported sizes up to 5 cm for individual masses, but larger ones are exceedingly rare. Positron emission tomography (PET) scan is also used in the detection of lymphoma in hyper IgE patients. This modality could be of interest in patients who cannot routinely undergo imaging with contrast media used in CT and MRI or those who have lesions which are not suitable for obtaining a biopsy [11].
Conclusion
We present a rare case of anaplastic large cell lymphoma in a young male patient who had previous infection with tuberculosis. Imaging in this patient unraveled a large mass in the mediastinum, which had encased the aorta. Further imaging showed numerous lymphadenopathies in the subcarinal and inguinal region. Open lung biopsy was done to attain a specimen for further analysis. IHC showed positive staining for CD30, and the diagnosis was made. This case report illustrates the duality of immune system dysfunction in individuals affected by hyper IgE syndrome. It is important for clinicians to address this duality in clinical practice and anticipate conditions resulting from defective immune system and also uncontrollable activation of the immune system.
Availability of data and materials
All data is available based on a reasonable request.
Abbreviations
- CD:
-
Cluster of differentiation
- CT scan:
-
Computed tomography scan
- Hyper IgE syndrome:
-
Hyper immunoglobulin E syndrome
- STAT3:
-
Signal transducer and activator of transcription 3
- TB:
-
Tuberculosis
References
- 1.
Davis S, Schaller J, Wedgwood R, Harvard M (1966) Job’s syndrome: recurrent, “cold”, staphylococcal abscesses. Lancet. 287(7445):1013–1015
- 2.
Mogensen TH (2013) STAT3 and the hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. Jak-Stat. 2(2):e23435
- 3.
Freeman AF, Holland SM (2008) The hyper-IgE syndromes. Immunol Allergy Clin North Am 28(2):277–291
- 4.
Freeman AF, Holland SM (2010) Clinical manifestations of hyper IgE syndromes. Disease markers. 29(3, 4):123–130
- 5.
Liza M, Gaurav D, Prasenjeet M, Swapna J, Binodini B (2018) Autosomal-recessive hyper-IgE syndrome. Indian J Dermatol 63(1):79
- 6.
Chu EY, Freeman AF, Jing H, Cowen EW, Davis J, Su HC et al (2012) Cutaneous manifestations of DOCK8 deficiency syndrome. Archives of dermatology. 148(1):79–84
- 7.
Kumánovics A, Perkins SL, Gilbert H, Cessna MH, Augustine NH, Hill HR (2010) Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol 30(6):886–893
- 8.
Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK (2003) Extensive xanthelasma associated with anaplastic large cell lymphoma and hyperimmunoglobulin E syndrome. Int J Dermatol 42(12):944–946
- 9.
Webb TR, Slavish J, George RE, Look AT, Xue L, Jiang Q et al (2009) Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Rev Anticancer Ther 9(3):331–356
- 10.
Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M et al (2002) Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 21(7):1038
- 11.
Friedberg JW, Chengazi V (2003) PET scans in the staging of lymphoma: current status. Oncologist. 8(5):438–447
Acknowledgements
We would like to thank Dr. Puri for his support in conducting this report.
Funding
No one was paid during this study. The study did not have a source of funding. This study was not supported by a grant.
Author information
Affiliations
Contributions
AK contributed to the data acquisition, manuscript preparation, and approval of the final version of the study. AS contributed to the oversight over the case report, data acquisition, and approval of the final version of the study. MMAA contributed to the manuscript preparation, revision of the manuscript and final edit, interpretation of imaging findings, and approval of the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The present study was approved by the ethical board of the hospital in which the study was performed. The patient reported in this article had signed a written informed consent form. This case report was a reporting of a case in a medical educational center, in which all patients are informed that they may be subjects of scientific experiments and are informed of the ethical codes of conducts. This study was in compliance to the latest version of the Helsinki Declaration.
Consent for publication
The patient had written and signed an informed consent note that the findings may be published without any personal detail.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Kheyrollahiyan, A., Sharifi, A. & Mirza-Aghazadeh-Attari, M. Systemic anaplastic large cell lymphoma presenting as a huge mediastinal mass in a case of hyper IgE syndrome: a case report. Egypt J Radiol Nucl Med 50, 36 (2019). https://doi.org/10.1186/s43055-019-0047-2
Received:
Accepted:
Published:
Keywords
- CT scan
- Hyper IgE syndrome
- Lymphoma
- Anaplastic large cell lymphoma
- Tuberculosis
